Black Health: Drug Research to Focus on African Americans

It has long been a complaint in the black community that little medical research is done to address diseases that disproportionately affect African Americans. That trend may be changing. According to a new report by the Pharmaceutical Research and Manufacturers of America, 691 new medicines are being developed to treat major diseases affecting blacks. According to Dr. Ian Smith, medical and diet expert on VH1's Celebrity Fit Club and creator and founder of The 50 Million Pound Challenge, the research is long overdue. "Research like this has been a long time coming and its emergence is due to several factors including market demand, the understanding of unique patient response to the same medications, and a realization that genetic differences between ethnic groups demand research that addresses these differences," says Smith. Among the medicines in development are 229 drugs for the treatment of cancers that disproportionately affect African Americans; 114 medicines for the treatment of cardiovascular disease (African Americans have the highest prevalence of high blood pressure in the world, according to the American Heart Association); 95 drugs to treat diabetes; 77 medicines to treat respiratory disorders (according to the American Lung Association, blacks have the highest asthma rate of any other ethnic group and are three times more likely to die from asthma than whites); and 67 medicines for the treatment of HIV (African Americans accounted for 49% of HIV cases diagnosed in 2005, according to the U.S. Centers for Disease Control and Prevention). SOURCE OF THIS STORY